Sun Pharmaceutical Industries has agreed to offer its prescription and future innovative drugs in the US at prices in line with the lowest paid by other developed nations, under ...
Indian benchmark stock indices Sensex and Nifty staged a significant rebound, snapping a three-day losing streak, fuelled by strong performances from Reliance Industries and Sun Pharma, coupled with positive ...
Mumbai: Dilip Shanghvi is going ahead with his biggest bet ever, by submitting a binding offer of $13 billion to acquire US-based Organon & Co, said people in the ...
The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC ...
Mumbai: Sun Pharmaceutical Industries has decided to proceed with a binding offer of $12 billion for Organon & Co, taking the company to the final stages of its most ...
Is AI in pharma just hype or a full-blown revolution? In this episode, ET's Anirban Chowdhury sits down with three industry heavyweights Sujay Shetty, Partner & Leader - Health ...
Despite global headwinds, India's pharmaceutical exports are booming, exceeding $28 billion and projecting significant growth, driven by strong performance in formulations, biologicals, and vaccines. Photograph:Yves Herman/Reuters Key Points India's ...
US-based private equity firm Warburg Pincus is in advanced discussions to acquire the formulations business of Mumbai-based Maneesh Pharmaceuticals in a deal valued around ₹1,600–1,800 crore, sources familiar with ...
Prabha Sinha, co-founder, ZSNew Delhi: In global healthcare today, adopting technology is no longer what sets organisations apart. It is simply the baseline. Most large pharmaceutical and medical device ...
Incremental gains for the company, and the listed pharma universe more broadly, also stemmed from positive sentiment around the India–US trade deal. About a third of Sun Pharma’s revenues ...